drugset / Trial / NCT05275855
First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of EDI048 in Healthy Volunteers
RandomizedSequentialDouble-blindTreatment
Summary
A first-in-human study to evaluate the safety, tolerability, and pharmacokinetics of single ascending doses and multiple ascending doses of EDI048 administered orally in healthy volunteers.
Timeline
- Start
- 2022-04-29
- Primary completion
- 2024-12-18
- Completion
- 2024-12-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EDI048 | Unknown | — | Oral |
Indications
No indication recorded.